<< Back to Educational Activities
Learn More & View Event »
On-Demand Programs
Show : Per page of 1
A Virtual Reality Experience on Targeted Treatments for Biliary Tract Cancers and Gastroesophageal Adenocarcinomas
This activity brings to life the unique mechanisms of action of bispecific antibodies, including novel, HER2-directed, biparatopic bispecific antibodies being studied for HER2-overexpressing biliary tract cancers (BTCs) and gastroesophageal adenocarcinomas (GEAs). This immersive 3D animation also reviews current and emerging treatment approaches for HER2-positive BTCs and GEAs, as well as efficacy and safety data from relevant clinical trials.
RELEASED DATE: August 02, 2024
EXPIRATION DATE: August 02, 2025
